Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 1 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 1

From: Role of multislice computed tomography 3D volumetric analysis in the assessment of the therapeutic response of hepatocellular carcinoma after transarterial chemoembolization

Fig. 1

A 66-year-old male with hepatitis C cirrhosis complicated by development of right lobe HCC. Child Pugh Score: A. BCLB: B. A Pre-TACE axial arterial phase image showing measurement of the lesion according to RECIST, B pre-TACE axial arterial phase image showing measurement of the lesion according to mRECIST and C pre-TACE axial arterial phase image showing measurement of the lesion according to vRECIST. D vRECIST 3D image showing the lesion’s volume, E post-TACE images showing lesion’s measurement according to RECIST, F measurement according to mRECIST by measuring the diameter of the enhancing component only, G volumetric assessment of the viable component only, H 3D image showing the volume of the viable component, I vRECIST of the whole lesion post TACE, and J 3D image of the whole lesion’s volume. According to mRECIST, the lesion shows stable disease (non-responder) (< 30% decrease in the diameter of viable component), while according to vRECIST, the lesion shows partial response (responder) (> 65% decrease in the diameter of viable enhancing component). This could be explained by the heterogeneity of the lesion which makes it difficult to measure a single diameter of the enhancing component which is better assessed by 3D images

Back to article page